In addition to in-house produced cPR3m, we used cPR3m provided by Dr. Preston to determine anti-cPR3m reactivity in a cohort of 37 consecutive PR3-ANCA positive WG patients. The gene discussed is PRTN3; the disease is granulomatosis with polyangiitis.